← Scroll for more →
DBV Technologies S.A. (DBVT)
Biological Products, (No Diagnostic Substances)
Latest Price
$9.49
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.50
P/B Ratio
18.91
Institutional Ownership
7.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Mpm Bioimpact LLC | 3.67M | $60.0M | 1.24% | -1.55M | 2026-06-30 |
| Siren, L.L.C. | 1.86M | $30.0M | 0.63% | -- | 2026-06-30 |
| Vivo Capital, LLC | 1.84M | $30.0M | 0.62% | -822.8K | 2026-06-30 |
| Perceptive Advisors LLC | 1.65M | $27.0M | 0.56% | +689.0K | 2026-06-30 |
| Baker Bros. Advisors LP | 1.46M | $23.0M | 0.49% | -- | 2026-06-30 |
| Artisan Partners Limited Partnership | 1.37M | $22.0M | 0.46% | -846.5K | 2026-06-30 |
| UBS Group AG | 1.31M | $21.0M | 0.44% | +1.23M | 2026-06-30 |
| Morgan Stanley | 954.9K | $15.0M | 0.32% | +808.8K | 2026-06-30 |
| Logos Global Management LP | 915.0K | $15.0M | 0.31% | +890.0K | 2026-06-30 |
| Patient Square Capital LP | 909.5K | $14.0M | 0.31% | +215.9K | 2026-06-30 |